GSK3β inhibition was observed in response to trehalose, which upregulated ERα and ERβ and protected APP/PS1 mice against dietary advanced glycation end product (dAGE)-induced neurotoxicity and cognitive impairment [53]. The gene discussed is GSK3B; the disease is Cognitive impairment.